Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 270851-270900 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT01033656
Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
PHASE2
Completed
23 participants
Started: Dec 31, 2005 · Completed: Apr 30, 2010
1 condition
11 sponsors
1 location
NCT00349167
PR-104 in Treating Patients With Advanced Solid Tumors
PHASE1
Completed
27 participants
Started: Dec 31, 2005 · Completed: Jun 30, 2007
1 condition
2 sponsors
1 location
NCT00268307
Bone Marrow Stem Cell Infusion Following a Heart Attack
PHASE1
Completed
41 participants
Started: Dec 31, 2005 · Completed: Sep 30, 2010
1 condition
2 sponsors
1 location
NCT00255762
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
PHASE2
Completed
47 participants
Started: Dec 31, 2005
2 conditions
1 sponsor
1 location
NCT00595322
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
NA
Completed
25 participants
Started: Dec 31, 2005 · Completed: May 31, 2017
3 conditions
3 sponsors
2 locations
NCT00278759
Unclogging the Pediatric Emergency Room: Impact of Rapid Viral Diagnostics
NA
Completed
275 participants
Started: Dec 31, 2005 · Completed: Dec 31, 2007
1 condition
2 sponsors
1 location
NCT00258011
Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease
PHASE3
Completed
3 participants
Started: Dec 31, 2005 · Completed: Oct 31, 2006
4 conditions
2 sponsors
2 locations
NCT00307151
Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV
PHASE2
Completed
452 participants
Started: Dec 31, 2005 · Completed: Dec 31, 2016
1 condition
3 sponsors
10 locations
NCT00288249
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
PHASE2
Completed
82 participants
Started: Dec 31, 2005 · Completed: Jan 31, 2009
2 conditions
1 sponsor
21 locations
NCT00267644
Ultrasound of the Inferior Vena Cava (IVC) and Dehydration Status in Pediatric Emergency Patients
N/A
Completed
76 participants
Started: Dec 31, 2005 · Completed: Sep 30, 2009
1 condition
1 sponsor
1 location
NCT00268879
Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
PHASE3
Completed
1,821 participants
Started: Dec 31, 2005 · Completed: Jan 31, 2008
1 condition
1 sponsor
1 location
NCT00260039
Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)
PHASE2
Completed
680 participants
Started: Dec 31, 2005 · Completed: Aug 31, 2007
3 conditions
1 sponsor
0 locations
NCT00725517
Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange
PHASE4
Completed
2 participants
Started: Dec 31, 2005 · Completed: Feb 28, 2007
2 conditions
1 sponsor
0 locations
NCT00303940
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
PHASE1
Completed
26 participants
Started: Dec 31, 2005 · Completed: Feb 28, 2010
8 conditions
2 sponsors
1 location
NCT00300911
Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction
PHASE4
Completed
45 participants
Started: Dec 31, 2005
1 condition
1 sponsor
1 location
NCT00267592
Safety and Efficacy of Talampanel in Glioblastoma Multiforme
PHASE2
Completed
72 participants
Started: Dec 31, 2005 · Completed: Feb 28, 2011
1 condition
1 sponsor
0 locations
NCT00303797
Sorafenib and Bortezomib in Treating Patients With Advanced Cancer
PHASE1
Completed
50 participants
Started: Dec 31, 2005
5 conditions
1 sponsor
1 location
NCT00358865
Checking the Usability of a Virtual Reality System in Children With Brain Injury
N/A
Completed
30 participants
Started: Dec 31, 2005 · Completed: Dec 31, 2006
1 condition
1 sponsor
1 location
NCT00244270
Cystic Fibrosis and Totally Implantable Vascular Access Devices
PHASE4
Completed
97 participants
Started: Dec 31, 2005 · Completed: Mar 31, 2009
2 conditions
2 sponsors
0 locations
NCT00273897
Electrical Polarization of the Brain in Corticobasal Syndrome
PHASE2
Completed
20 participants
Started: Dec 30, 2005
1 condition
1 sponsor
1 location
NCT00474617
Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)
PHASE3
Completed
162 participants
Started: Dec 29, 2005 · Completed: Oct 20, 2006
1 condition
1 sponsor
0 locations
NCT00272363
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
N/A
Completed
484 participants
Started: Dec 29, 2005 · Completed: Jul 29, 2016
1 condition
1 sponsor
4 locations
NCT00272350
ZD6474 to Treat Advanced Brain Cancer in Patients
PHASE1
Completed
83 participants
Started: Dec 29, 2005 · Completed: Feb 27, 2014
3 conditions
1 sponsor
1 location
NCT00252382
Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC
PHASE2
Completed
31 participants
Started: Dec 27, 2005 · Completed: Nov 29, 2007
1 condition
1 sponsor
4 locations
NCT00245960
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
PHASE4
Completed
752 participants
Started: Dec 27, 2005 · Completed: Mar 29, 2008
1 condition
1 sponsor
120 locations
NCT00079417
Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma
PHASE3
Completed
28 participants
Started: Dec 26, 2005 · Completed: Mar 31, 2017
1 condition
2 sponsors
10 locations
NCT01062360
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
PHASE3
Completed
1,016 participants
Started: Dec 23, 2005 · Completed: May 14, 2007
2 conditions
1 sponsor
59 locations
NCT00270452
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
PHASE1
Completed
9 participants
Started: Dec 22, 2005 · Completed: Oct 26, 2007
1 condition
1 sponsor
1 location
NCT00326209
Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission
PHASE3
Completed
393 participants
Started: Dec 22, 2005 · Completed: May 5, 2008
1 condition
1 sponsor
61 locations
NCT04755023
Primary Chemotherapy by BCNU-TMZ Combination in Newly Diagnosed Anaplastic Oligodendrocytic Tumors: Phase II Trial With Translational Molecular Analysis
PHASE2
Completed
53 participants
Started: Dec 21, 2005 · Completed: Dec 15, 2010
1 condition
1 sponsor
1 location
NCT00272376
Clinical and Genetic Studies in Families With Myopia and Related Diseases
N/A
Completed
851 participants
Started: Dec 21, 2005 · Completed: Jul 29, 2016
1 condition
1 sponsor
2 locations
NCT00270478
Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
PHASE1
Completed
7 participants
Started: Dec 21, 2005 · Completed: Aug 31, 2009
3 conditions
1 sponsor
1 location
NCT00270465
Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients
PHASE1
Completed
17 participants
Started: Dec 21, 2005 · Completed: Jun 25, 2009
1 condition
1 sponsor
1 location
NCT00080938
Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
PHASE2
Completed
26 participants
Started: Dec 20, 2005 · Completed: Feb 28, 2009
2 conditions
2 sponsors
0 locations
NCT00242385
Pharmacokinetic Study of ARALAST (Human Alpha1- PI)
PHASE1
Completed
25 participants
Started: Dec 20, 2005 · Completed: Jun 5, 2006
1 condition
2 sponsors
7 locations
NCT00126672
RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS
PHASE2
Completed
36 participants
Started: Dec 20, 2005 · Completed: Apr 30, 2010
4 conditions
4 sponsors
7 locations
NCT00579527
Phase I/II Thymus Transplantation With Immunosuppression #950
PHASE1/PHASE2
Completed
14 participants
Started: Dec 19, 2005 · Completed: Dec 31, 2017
5 conditions
4 sponsors
1 location
NCT00298038
A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy
PHASE3
Completed
299 participants
Started: Dec 19, 2005 · Completed: Aug 15, 2008
1 condition
1 sponsor
0 locations
NCT00091169
Levocarnitine in Treating Fatigue in Cancer Patients
PHASE3
Completed
376 participants
Started: Dec 16, 2005 · Completed: May 31, 2011
2 conditions
2 sponsors
116 locations
NCT01682187
A Dose-Escalation Study in Participants With Recurrent Malignant Glioma
PHASE1
Completed
66 participants
Started: Dec 15, 2005 · Completed: Sep 30, 2024
1 condition
1 sponsor
4 locations
NCT00267891
Brain Changes in Adolescents While Imagining and Observing Aggressive Behavior
N/A
Completed
88 participants
Started: Dec 14, 2005 · Completed: Aug 12, 2010
1 condition
1 sponsor
1 location
NCT00295932
Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
PHASE1/PHASE2
Completed
79 participants
Started: Dec 13, 2005 · Completed: Mar 11, 2018
2 conditions
5 sponsors
8 locations
NCT00582257
Early Onset and Familial Gastric Cancer Registry
N/A
Completed
971 participants
Started: Dec 13, 2005 · Completed: Sep 30, 2024
1 condition
6 sponsors
10 locations
NCT00266500
Body Heat Content and Dissipation in Obese and Normal Weight Adults
N/A
Completed
80 participants
Started: Dec 12, 2005 · Completed: Oct 28, 2014
1 condition
1 sponsor
1 location
NCT00086567
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
N/A
Completed
119 participants
Started: Dec 12, 2005
3 conditions
1 sponsor
11 locations
NCT00279019
Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease
PHASE1
Completed
31 participants
Started: Dec 12, 2005 · Completed: Jun 13, 2006
1 condition
1 sponsor
3 locations
NCT00702351
A Trial of Single Dose Corifollitropin Alfa's Ability to Induce Multiple Follicular Growth During the First Week of Controlled Ovarian Stimulation for IVF or ICSI (38833)(P05788)
PHASE2
Completed
50 participants
Started: Dec 9, 2005 · Completed: Jul 11, 2007
1 condition
1 sponsor
0 locations
NCT01089322
Risk Factors Associated to Difficult-to-control Asthma
PHASE4
Completed
74 participants
Started: Dec 9, 2005 · Completed: May 13, 2009
1 condition
2 sponsors
1 location
NCT00507728
Pharmacogenetics, Emotional Reactivity and Smoking
PHASE2/PHASE3
Completed
646 participants
Started: Dec 8, 2005 · Completed: Dec 18, 2019
2 conditions
3 sponsors
1 location
NCT01112358
Lutropin Alfa in Women at Risk of Poor Response
PHASE2
Completed
58 participants
Started: Dec 7, 2005 · Completed: Jan 30, 2007
1 condition
1 sponsor
1 location
Previous
1
More pages
5415
5416
5417
5418
5419
5420
5421
More pages
6093
Next